Pennsylvania Cancer Alliance Honors U.S. Representative John P. Murtha for His Support of Cancer Research Funding
PHILADELPHIA (January 23, 2004) -- The Pennsylvania Cancer Alliance, a consortium of the Commonwealth's top cancer centers, will honor U.S. Representative John P. Murtha (PA-12) on Monday, January 26, 2004, during a reception from 5:30 to 7:30 p.m. at the Whitaker Center's Kunkel Gallery, 222 Market Street, Harrisburg, Pa. The PCA selected Murtha to receive its annual award because of his long-standing support of cancer research funding while serving Pennsylvania's 12th District in Congress.
Through his leadership role on the U.S. House Defense Appropriations Committee, Murtha successfully spearheaded the effort to establish a cancer research program within the Department of Defense. In 1993, the United States Army Medical Research and Materiel Command organized the Congressionally Directed Medical Research Programs (CDMRP). With the continued leadership of Murtha, the CDMRP has expanded to become second only to the National Cancer Institute as a source of funding for breast cancer research. The CDMRP manages research initiatives in women's health, breast cancer, osteoporosis, neurofibromatosis, prostate cancer, ovarian cancer, tuberous sclerosis, and chronic myelogenous leukemia.
From the inception of the programs in 1992 through September 2003, CDMRP has awarded 360 grants at 25 Pennsylvania institutions totaling more than $128 million. Nationwide, congressional appropriations for research totals more than $2.6 billion since the CDMRP inception.
The Pennsylvania Cancer Alliance is dedicated to reducing the burden of cancer on the citizens of the Commonwealth of Pennsylvania by pursuing world-class basic and clinical research to improve cancer prevention and advance the standard of cancer care available statewide. The members of the Alliance are Pennsylvania's leading cancer centers: Fox Chase Cancer Center, Philadelphia; Pennsylvania State University, Hershey; Temple University, Philadelphia; Thomas Jefferson University, Philadelphia; University of Pennsylvania, Philadelphia; University of Pittsburgh, Pittsburgh; and The Wistar Institute, Philadelphia.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.